Article
APOE ε4–associated heterogeneity of neuroimaging biomarkers across the Alzheimer's disease continuum
22 Nov 2024
Abstract excerpt
INTRODUCTION: While the role of apolipoprotein E (APOE) ε4 in Alzheimer's disease (AD) susceptibility has been studied extensively, much less is known about the differences in disease presentation in APOE ε4 carriers versus non-carriers. METHODS: To help elucidate these differences, we performed a broad analysis comparing the regional levels of six different neuroimaging biomarkers in the brains of APOE ε4...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
